GUT LINK: A Pilot Study to Evaluate the Comparative Effectiveness of an Evidence-based Care Pathway Across Primary and GI Specialty Care

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

It can be challenging for Primary Healthcare Providers (PHCPs) to differentiate between IBS and more serious illnesses involving the GI tract, such as Crohn's disease, ulcerative colitis, or cancer. To help with diagnosis and treatment of IBS, evidence-based guidelines have been developed. However, they are not commonly used in primary care practice and PHCPs and patients often feel that GI specialist evaluation and endoscopy is required. The development of care pathways and clinical practice guidelines is essential to support the investigation and management of digestive diseases, such as IBS. The current pilot study is designed to assess the implementation and early comparative effectiveness of a Clinical Care Pathway for lower GI tract symptoms.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: t
View:

• Must be a general practitioner

• Have a family practice in Nova Scotia, Canada

• Utilize the platform 'virtual hallway' as part of current referral practices

• Deliver care to patients with lower GI complaints

Locations
Other Locations
Canada
QEII Health Sciences Centre
RECRUITING
Halifax
Contact Information
Primary
Michael Stewart, MD
Michael.Stewart@Dal.ca
1(902) 473-2222 xt. 2526
Backup
Natalie Willett, BSc
natalie.willett@nshealth.ca
902-473-7074
Time Frame
Start Date: 2024-02-01
Estimated Completion Date: 2026-12
Participants
Target number of participants: 120
Treatments
Experimental: GUT LINK SmartPath
physicians will use the interactive GUT LINK Smartpath tool in virtual hallway platform to guide their care and referral practices
No_intervention: control
physicians will provide care and refer as per their usual practices
Sponsors
Leads: Michael Stewart
Collaborators: Nova Scotia Health Authority

This content was sourced from clinicaltrials.gov